Antiamyloid therapy for Alzheimer's disease - Are we on the right road?

New England Journal of Medicine

Volumn 370, Issue 4, 2014, Pages 377-378

  Karran, Eric ^a,b   Hardy, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Alzheimer's Research UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN A4; BAPINEUZUMAB; SOLANEZUMAB; TAU PROTEIN;

ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ALZHEIMER DISEASE COOPERATIVE STUDY ACTIVITIES OF DAILY LIVING SCALE; AMYLOID PLAQUE; BRAIN EDEMA; BRAIN SIZE; CEREBROSPINAL FLUID LEVEL; DEMENTIA; EDITORIAL; HUMAN; METABOLITE; NERVE INJURY; NEUROFIBRILLARY TANGLE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RATING SCALE;

EID: 84892710970     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1313943     Document Type: Editorial

References (7)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-6. [Erratum, Science 2002;297:2209.]
2. Salloway S, Sperling R, Fox NC, et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med 2014;370:322-33.
3. Doody RS, Thomas RG, Farlow M, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med 2014;370:311-21.
4. Demattos RB, Lu J, Tang Y, et al. A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice. Neuron 2012;76:908-20.
5. Maia LF, Kaeser SA, Reichwald J, et al. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein. Sci Transl Med 2013;5(194): 194re2.
6. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2001;98: 8850-5.
7. Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011;10:698-712.